Kidney Neoplasms
82
11
14
37
Key Insights
Highlights
Success Rate
70% trial completion
Published Results
17 trials with published results (21%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
19.5%
16 terminated out of 82 trials
69.8%
-16.7% vs benchmark
11%
9 trials in Phase 3/4
46%
17 of 37 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 37 completed trials
Clinical Trials (82)
Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
Savolitinib vs. Sunitinib in MET-driven PRCC.
Multimodal Prediction of Postoperative Prognosis After Partial Nephrectomy for Endophytic Renal Cell Carcinoma
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
CD70-targeted immunoPET Imaging of Kidney Cancer
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal Cancer
The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy
A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India
HTL0039732 in Participants With Advanced Solid Tumours
Planning Operative Strategy Using a Digital Renal Artery Clamping Tool
Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American